Skip to main content
Clinical Trials/NCT05907551
NCT05907551
Recruiting
Not Applicable

Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions

Institut de cancérologie Strasbourg Europe1 site in 1 country210 target enrollmentJuly 25, 2023
ConditionsNeoplasms

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Institut de cancérologie Strasbourg Europe
Enrollment
210
Locations
1
Primary Endpoint
Describe patients' knowledges regarding dermo-cosmetics and aesthetic solutions that can attenuate cutaneous side-effects, nail and hair toxicities induced by anticancer drugs
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Cancer treatments can trigger cutaneous side-effects, as well as nail and hair toxicities. When related to drug treatment, this iatrogeny depends on the type of drug, its dosage and individual susceptibility. Although these dermatological adverse events are rarely serious, they can significantly alter patients' quality of life, and may even necessitate the introduction of curative treatment.

The impact of these side effects can be mitigated by the use of dermo-cosmetic products and aesthetic solutions. However, most of this supportive care is not reimbursed by the health insurance system, representing a source of inequalities in access to healthcare for cancer patients.

Detailed Description

This study aims at establishing, in a cohort of patients with solid tumors, the state of their knowledges, given information and their financial capacities regarding access to dermo-cosmetics and aesthetic solutions, that are used in the attenuation of cancer treatments' side-effects.

Registry
clinicaltrials.gov
Start Date
July 25, 2023
End Date
October 25, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Institut de cancérologie Strasbourg Europe
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • Patients with solid tumors (eligible localization include: digestive system, Head and Neck, Breast, Brain, Lung Tumors, Urological and Gynecologic cancers)
  • Patients able to read and understand French
  • Patients that has expressed their consent and with signed consent form

Exclusion Criteria

  • Minor or patients placed under guardianship or supervision
  • Patients unable to read French
  • Patients placed under judicial protection

Outcomes

Primary Outcomes

Describe patients' knowledges regarding dermo-cosmetics and aesthetic solutions that can attenuate cutaneous side-effects, nail and hair toxicities induced by anticancer drugs

Time Frame: at inclusion

10 items questionnaires

Describe patients' knowledges regarding cutaneous side-effects, nail and hair toxicities induced by anticancer drugs

Time Frame: at inclusion

4 items questionnaires

Secondary Outcomes

  • Correlate patients' knowledge level depending on tumoral location(at inclusion)
  • Correlate patients' knowledge level depending on treatment phase(at inclusion)
  • Describe patients' socio-economic profile to assess equity regarding access to dermo-cosmetics and aesthetic solutions(at inclusion)
  • Correlate patients' knowledge level depending on received treatment(at inclusion)

Study Sites (1)

Loading locations...

Similar Trials